Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Roberts

Showing results (481-490 of 609) with videos related to

Pageof 61
Sort By:
The Journal of Antimicrobial Chemotherapy|December 23, 2017
Population pharmacokinetics of total and unbound teicoplanin concentrations and dosing simulations in patients with haematological malignancyCatherine J Byrne, Ted Parton, Brett McWhinney, et al.
BMJ Open|August 10, 2013
A Protocol for the Pharmacokinetics of Enteric Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN): an open-label, randomised controlled trialDwarakanathan Ranganathan, George T John, Helen Healy, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2018
Optimization and Evaluation of Piperacillin-Tobramycin Combination Dosage Regimens against Pseudomonas aeruginosa for Patients with Altered Pharmacokinetics via the Hollow-Fiber Infection Model and Mechanism-Based ModelingRajbharan Yadav, Kate E Rogers, Phillip J Bergen, et al.
Antibiotics (Basel, Switzerland)|November 13, 2020
Vancomycin Serum Concentration after 48 h of Administration: A 3-Years Survey in an Intensive Care UnitNicolas Perin, Claire Roger, Grégory Marin, et al.
Antimicrobial Agents and Chemotherapy|August 24, 2016
Effect of Obesity on the Population Pharmacokinetics of Fluconazole in Critically Ill PatientsAbdulaziz S Alobaid, Steven C Wallis, Paul Jarrett, et al.
Journal of Pharmaceutical Sciences|March 2, 2020
Population Pharmacokinetics and Dosing Recommendations of Levetiracetam in Adult and Elderly Patients With EpilepsyMaría Patricia Hernández-Mitre, Susanna Edith Medellín-Garibay, Ildefonso Rodríguez-Leyva, et al.
Critical Care (London, England)|April 16, 2018
Population pharmacokinetics/pharmacodynamics of micafungin against Candida species in obese, critically ill, and morbidly obese critically ill patientsEmilio Maseda, Santiago Grau, Sonia Luque, et al.
Antimicrobial Agents and Chemotherapy|January 6, 2017
Population Pharmacokinetics of Piperacillin in Nonobese, Obese, and Morbidly Obese Critically Ill PatientsAbdulaziz S Alobaid, Steven C Wallis, Paul Jarrett, et al.
Antibiotics (Basel, Switzerland)|December 24, 2021
Is Dosing of Ethambutol as Part of a Fixed-Dose Combination Product Optimal for Mechanically Ventilated ICU Patients with Tuberculosis? A Population Pharmacokinetic StudyFrancisco Beraldi-Magalhaes, Suzanne L Parker, Cristina Sanches, et al.
Antimicrobial Agents and Chemotherapy|October 17, 2025
Efficacy, safety, and population pharmacokinetics of a single 1500mg dose of dalbavancin for short-term therapy in patients with chronic prosthetic joint infectionsEva Benavent, Jaime Lora-Tamayo, Marta Ulldemolins, et al.
Pageof 61

Showing results (481-490 of 609) with videos related to

Sort By:
Pageof 61
The Journal of Antimicrobial Chemotherapy|December 23, 2017
Population pharmacokinetics of total and unbound teicoplanin concentrations and dosing simulations in patients with haematological malignancyCatherine J Byrne, Ted Parton, Brett McWhinney, et al.
BMJ Open|August 10, 2013
A Protocol for the Pharmacokinetics of Enteric Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN): an open-label, randomised controlled trialDwarakanathan Ranganathan, George T John, Helen Healy, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2018
Optimization and Evaluation of Piperacillin-Tobramycin Combination Dosage Regimens against Pseudomonas aeruginosa for Patients with Altered Pharmacokinetics via the Hollow-Fiber Infection Model and Mechanism-Based ModelingRajbharan Yadav, Kate E Rogers, Phillip J Bergen, et al.
Antibiotics (Basel, Switzerland)|November 13, 2020
Vancomycin Serum Concentration after 48 h of Administration: A 3-Years Survey in an Intensive Care UnitNicolas Perin, Claire Roger, Grégory Marin, et al.
Antimicrobial Agents and Chemotherapy|August 24, 2016
Effect of Obesity on the Population Pharmacokinetics of Fluconazole in Critically Ill PatientsAbdulaziz S Alobaid, Steven C Wallis, Paul Jarrett, et al.
Journal of Pharmaceutical Sciences|March 2, 2020
Population Pharmacokinetics and Dosing Recommendations of Levetiracetam in Adult and Elderly Patients With EpilepsyMaría Patricia Hernández-Mitre, Susanna Edith Medellín-Garibay, Ildefonso Rodríguez-Leyva, et al.
Critical Care (London, England)|April 16, 2018
Population pharmacokinetics/pharmacodynamics of micafungin against Candida species in obese, critically ill, and morbidly obese critically ill patientsEmilio Maseda, Santiago Grau, Sonia Luque, et al.
Antimicrobial Agents and Chemotherapy|January 6, 2017
Population Pharmacokinetics of Piperacillin in Nonobese, Obese, and Morbidly Obese Critically Ill PatientsAbdulaziz S Alobaid, Steven C Wallis, Paul Jarrett, et al.
Antibiotics (Basel, Switzerland)|December 24, 2021
Is Dosing of Ethambutol as Part of a Fixed-Dose Combination Product Optimal for Mechanically Ventilated ICU Patients with Tuberculosis? A Population Pharmacokinetic StudyFrancisco Beraldi-Magalhaes, Suzanne L Parker, Cristina Sanches, et al.
Antimicrobial Agents and Chemotherapy|October 17, 2025
Efficacy, safety, and population pharmacokinetics of a single 1500mg dose of dalbavancin for short-term therapy in patients with chronic prosthetic joint infectionsEva Benavent, Jaime Lora-Tamayo, Marta Ulldemolins, et al.
Pageof 61